SCHEMBL25722136

SCHEMBL25722136

OBOc1cccc(-c2nc(-c3ccccc3)cc(-c3ccccc3)n2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.50
▸ KMT2A Q03164 6/20 0.50
▸ MAPT P10636 4/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ HPGD P15428 4/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ LMNA P02545 2/20 0.50
▸ MAPK1 P28482 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ NTSR1 P30989 1/20 0.49
▸ MAOB P27338 3/20 0.48
▸ MAOA P21397 2/20 0.47
▸ GLA P06280 1/20 0.43
▸ ADORA2A P29274 3/20 0.42
▸ ADORA1 P30542 3/20 0.42
▸ TSHR P16473 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25722116 0.95 MAOB (0.54) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25722125 0.92 MEN1 (0.53) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25722080 0.92 MAOB (0.51) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25722098 0.92 MAOB (0.53) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL15761467 0.90 MAPK1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25722117 0.87 CYP1A2 (0.42) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25582624 0.87 MCL1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25722135 0.86 MCL1 (0.47) MEN1KMT2AMAPK1TDP1MAOB
SCHEMBL25582672 0.86 MCL1 (0.43) MEN1KMT2AMAPTMAPK1TDP1
SCHEMBL25722103 0.85 MEN1 (0.59) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11690289-B2 Organic compound containing heterocyclic ring and having low lumo properties, and organic electroluminescent device using the same SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11690289-B2 Organic compound containing heterocyclic ring and having low lumo properties, and organic electroluminescent device using the same LEF1, PPOX, LIMK1 MEN1 1500/4885KMT2A 1677/4885MAPT 2035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback